Mindfulness-based cognitive therapy can impact how individuals with recurrent depressive disorder relate to themselves.
With little being known about the predictors or moderators of dTMS outcome for OCD, this study sought to examine if several theoretically relevant variables may predict and moderate treatment effects including OCD symptom severity, functional impairment, co-occurring depressive symptoms, age, gender, age of OCD onset, and family history of OCD.
This study addresses the question of whether prescription opioid medications has a potentially causal role in the risk for depression and anxiety disorder.
This systematic review and meta-analysis examines the longitudinal association between depression and subsequent attainment, and its potential effect modifiers and mediators.
Sildenafil and trazodone tablets have been recalled by pharmaceutical distributor AvKARE because the drugs were “inadvertently packaged together” when they were bottled by a third-party vendor.
Specific structural changes in the brain may indicate genetic risk for schizophrenia and suggest different neurobiological pathways to the disorder.
Childhood ADHD risk was increased among children who were exposed to maternal hypothyroidism during the periconceptual period.
While statins have both good and bad outcomes in the realm of neuropsychiatry, researchers looked at the possible associations with statins and suicidality, depression, anxiety, and seizures.
This study provides evidence that the disruption of protein synthesis in discrete inhibitory neuron subpopulations in the centrolateral amygdala impairs associative memories related to threat and safety, which may contribute to maladaptive behavior in memory disorders such as PTSD.
Investigating whether serial ketamine treatments change functional connectivity between limbic structures and resting-state networks.